334 related articles for article (PubMed ID: 21150778)
1. Clinical predictors for progression of nonintervened nonculprit coronary lesions despite low-density lipoprotein cholesterol less than 1.8 mmol/l after successful stent implantation.
Yin ZX; Zhou YJ; Liu XL; Han HY; Yang SW
Coron Artery Dis; 2011 Mar; 22(1):49-54. PubMed ID: 21150778
[TBL] [Abstract][Full Text] [Related]
2. [Different effects of inflammation and lipid levels on coronary lesions after PCI].
Xu HY; Qiao SB; Li JJ; Yang YJ; Zhang JF; Xu B; Xie GQ; Dong QT
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2249-52. PubMed ID: 20095335
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome.
Nakachi T; Kosuge M; Hibi K; Ebina T; Hashiba K; Mitsuhashi T; Endo M; Umemura S; Kimura K
Circ J; 2008 Dec; 72(12):1953-9. PubMed ID: 18957790
[TBL] [Abstract][Full Text] [Related]
4. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
5. Long-term percutaneous coronary intervention rates and associated independent predictors for progression of nonintervened nonculprit coronary lesions.
Park MW; Seung KB; Kim PJ; Park HJ; Yoon SG; Baek JY; Koh YS; Jung HO; Chang K; Kim HY; Baek SH
Am J Cardiol; 2009 Sep; 104(5):648-52. PubMed ID: 19699339
[TBL] [Abstract][Full Text] [Related]
6. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
7. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
9. Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.
Shiiba M; Zhang B; Miura SI; Ike A; Nose D; Kuwano T; Imaizumi S; Sugihara M; Iwata A; Nishikawa H; Kawamura A; Shirai K; Yasunaga S; Saku K
Heart Vessels; 2018 Feb; 33(2):102-112. PubMed ID: 28815384
[TBL] [Abstract][Full Text] [Related]
10. Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents.
Kim BK; Kim DW; Oh S; Yoon SJ; Park S; Jeon DW; Yang JY
Coron Artery Dis; 2010 May; 21(3):182-8. PubMed ID: 20168221
[TBL] [Abstract][Full Text] [Related]
11. Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.
Koncsos P; Fülöp P; Juhász I; Bíró K; Márk L; Simonyi G; Paragh G
Wien Klin Wochenschr; 2016 Dec; 128(23-24):858-863. PubMed ID: 27380508
[TBL] [Abstract][Full Text] [Related]
12. [The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction].
Li Z; Tao Y; Huang J; Wang Q; Zhang DH; Wu XY
Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1458-62. PubMed ID: 24029567
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
14. The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.
Qiu W; Chen J; Huang X; Guo J
Lipids Health Dis; 2020 Jul; 19(1):163. PubMed ID: 32631347
[TBL] [Abstract][Full Text] [Related]
15. Characteristics Detected on Computed Tomography Angiography Predict Coronary Artery Plaque Progression in Non-Culprit Lesions.
Tan Y; Zhou J; Zhou Y; Yang X; Yang J; Chen Y
Korean J Radiol; 2017; 18(3):487-497. PubMed ID: 28458601
[TBL] [Abstract][Full Text] [Related]
16. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.
Marso SP; Mercado N; Maehara A; Weisz G; Mintz GS; McPherson J; Schiele F; Dudek D; Fahy M; Xu K; Lansky A; Templin B; Zhang Z; de Bruyne B; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S42-52. PubMed ID: 22421230
[TBL] [Abstract][Full Text] [Related]
17. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
18. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
[TBL] [Abstract][Full Text] [Related]
19. Elevated lipoprotein-associated phospholipase A2 is associated with progression of nonculprit lesions after percutaneous coronary intervention.
Xin H; Gong HP; Cai SL; Ning XF; Liu S; Chen ZY; Lian ZX; Zhang R; Zhang QF; Kang WQ; Ge ZM
Tohoku J Exp Med; 2013 Jun; 230(2):97-102. PubMed ID: 23774398
[TBL] [Abstract][Full Text] [Related]
20. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
